首頁 > 市場調查報告書 > 醫療設備

傷口護理

市場調查報告書

商品編碼

1578302

全球萎縮性疤痕治療市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Atrophic Scar Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年09月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球萎縮性疤痕治療市場需求預計將從 2023 年的 270.2 億美元達到 2032 年近 615.6 億美元的市場規模，2024-2032 年研究期間複合年成長率為 9.58%。

萎縮性疤痕是由於嚴重痤瘡、水痘或去除痣而在皮膚上形成的疤痕。這些疤痕的形成是因為儘管皮膚下面癒合了，但皮膚無法再生組織。萎縮性疤痕治療用於減少疤痕的出現。這些疤痕會對生活品質產生重大影響，但對皮膚科醫生來說是一個治療挑戰。根據疤痕的形態，採用化學換膚、磨皮、雷射治療、針刺、幹細胞治療等多種治療技術。在最壞的情況下，選擇各種治療方法的組合來進行有效的治療。這些技術也用於治療交通事故、燒傷和皮膚再生造成的疤痕。

市場動態

由於皮膚病的增加，萎縮性疤痕治療的市場正在飆升。對抗老化治療的需求、個人護理費用的激增、醫療保健領域費用的增加、公司提供的報銷改善將推動該市場的成長。對治療替代方案和創新的認知的提高是推動萎縮性疤痕治療市場的其他因素。 COVID-19 對萎縮性疤痕治療技術的影響很小，因為病毒似乎對感染者的皮膚沒有任何影響。市場面臨的主要挑戰是治療萎縮性疤痕的高成本。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球萎縮性疤痕治療市場的每個細分市場進行了包容性評估。萎縮性疤痕治療產業的成長和趨勢為本研究提供了整體方法。

市場區隔

萎縮性疤痕治療市場報告的這一部分提供了有關國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按配銷通路

藥局和藥局
醫院
電子商務
診所和皮膚科中心

依產品類型

雷射
專題
可注射
表面處理

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲萎縮性疤痕治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。萎縮性疤痕治療市場的主要參與者包括艾爾建（AbbVie）、Galderma、Merz Pharma、Cynosure、Syneron Candela、Lumenis、Cutera、Sciton、Alma Lasers、Sinclair Pharma、Suneva Medical、強生、Bausch Health Companies、Revance Therapeutics 、遠藤國際、賽諾菲、雀巢皮膚健康。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：萎縮性疤痕治療公司的競爭格局

萎縮性疤痕治療市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Allergan (AbbVie)

公司概況
公司收入
產品
最新動態

Galderma

公司概況
公司收入
產品
最新動態

Merz Pharma

公司概況
公司收入
產品
最新動態

Cynosure

公司概況
公司收入
產品
最新動態

Syneron Candela

公司概況
公司收入
產品
最新動態

Lumenis

公司概況
公司收入
產品
最新動態

Cutera

公司概況
公司收入
產品
最新動態

Sciton

公司概況
公司收入
產品
最新動態

Alma Lasers

公司概況
公司收入
產品
最新動態

Sinclair Pharma

公司概況
公司收入
產品
最新動態

Suneva Medical

公司概況
公司收入
產品
最新動態

Johnson & Johnson

公司概況
公司收入
產品
最新動態

Bausch Health Companies

公司概況
公司收入
產品
最新動態

Revance Therapeutics

公司概況
公司收入
產品
最新動態

Endo International

公司概況
公司收入
產品
最新動態

Sanofi

公司概況
公司收入
產品
最新動態

Nestle Skin Health

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11211987

The global demand for Atrophic Scar Treatment Market is presumed to reach the market size of nearly USD 61.56 Billion by 2032 from USD 27.02 Billion in 2023 with a CAGR of 9.58% under the study period 2024-2032.

Atrophic scars are scars formed on the skin due to severe acne, chicken pox or mole removal. These scars are formed because though healed beneath, the skin is unable to regenerate tissue. Atrophic scar treatment is used to reduce the appearance of scars. These scars can have significant impact on the quality of life but is a therapeutic challenge for dermatologists. Based on the morphology of scars various treatment techniques like chemical peeling, dermabrasion, laser treatment, needling, stem cell therapy, etc are used. In worst-case scenarios, a combination of various treatment is chosen for effective treatment. These techniques are also used to treat scars caused by road accidents, burn injuries and skin rejuvenation.

MARKET DYNAMICS

The market for atrophic scar treatment is soaring high due to the increase in skin disorders. Demand for age-defying treatment therapies, surge in expenses on personal care, increased expenses in the area of health care, improved reimbursements offered by firms will propel the growth of this market. Increased awareness of treatment alternatives and innovations are other factors that will boost the market for atrophic scar treatment. The impact of COVID-19 on the atrophic scar treatment techniques is minimal since the virus does not seem to have any effect on the skin of the infected. The main challenge faced by this market is the high costs involved in the treatment of atrophic scars.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Atrophic Scar Treatment. The growth and trends of Atrophic Scar Treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Atrophic Scar Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Distribution Channel

Pharmacies & Drug Stores
Hospitals
E-Commerce
Clinics & Dermatology Centers

By Product Type

Laser
Topical
Injectable
Surface Treatment

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Atrophic Scar Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Atrophic Scar Treatment market include Allergan (AbbVie), Galderma, Merz Pharma, Cynosure, Syneron Candela, Lumenis, Cutera, Sciton, Alma Lasers, Sinclair Pharma, Suneva Medical, Johnson & Johnson, Bausch Health Companies, Revance Therapeutics, Endo International, Sanofi, Nestle Skin Health. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ATROPHIC SCAR TREATMENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Distribution Channel
- 3.7.2 Market Attractiveness Analysis By Product Type
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ATROPHIC SCAR TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL

5.1. Overview By Distribution Channel
5.2. Historical and Forecast Data Analysis By Distribution Channel
5.3. Pharmacies & Drug Stores Historic and Forecast Sales By Regions
5.4. Hospitals Historic and Forecast Sales By Regions
5.5. E-Commerce Historic and Forecast Sales By Regions
5.6. Clinics & Dermatology Centers Historic and Forecast Sales By Regions

6. GLOBAL ATROPHIC SCAR TREATMENT MARKET ANALYSIS BY PRODUCT TYPE

6.1. Overview By Product Type
6.2. Historical and Forecast Data Analysis By Product Type
6.3. Laser Historic and Forecast Sales By Regions
6.4. Topical Historic and Forecast Sales By Regions
6.5. Injectable Historic and Forecast Sales By Regions
6.6. Surface Treatment Historic and Forecast Sales By Regions

7. GLOBAL ATROPHIC SCAR TREATMENT MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE ATROPHIC SCAR TREATMENT COMPANIES

8.1. Atrophic Scar Treatment Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF ATROPHIC SCAR TREATMENT INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Allergan (AbbVie)
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Galderma
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Merz Pharma
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Cynosure
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Syneron Candela
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Lumenis
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Cutera
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Sciton
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Alma Lasers
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Sinclair Pharma
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments
9.13. Suneva Medical
- 9.13.1 Company Overview
- 9.13.2 Company Revenue
- 9.13.3 Products
- 9.13.4 Recent Developments
9.14. Johnson & Johnson
- 9.14.1 Company Overview
- 9.14.2 Company Revenue
- 9.14.3 Products
- 9.14.4 Recent Developments
9.15. Bausch Health Companies
- 9.15.1 Company Overview
- 9.15.2 Company Revenue
- 9.15.3 Products
- 9.15.4 Recent Developments
9.16. Revance Therapeutics
- 9.16.1 Company Overview
- 9.16.2 Company Revenue
- 9.16.3 Products
- 9.16.4 Recent Developments
9.17. Endo International
- 9.17.1 Company Overview
- 9.17.2 Company Revenue
- 9.17.3 Products
- 9.17.4 Recent Developments
9.18. Sanofi
- 9.18.1 Company Overview
- 9.18.2 Company Revenue
- 9.18.3 Products
- 9.18.4 Recent Developments
9.19. Nestle Skin Health
- 9.19.1 Company Overview
- 9.19.2 Company Revenue
- 9.19.3 Products
- 9.19.4 Recent Developments